Finally, momentum on this issue—reducing bureaucracy benefits not just industry but is crucial for patients as well

The designated Health Commissioner Oliver Varhelyi made clear commitments regarding the revision of medical devices during his hearing before the European Parliament's Committee on Environment and Public Health. "In response to my question, he assured me that, following Parliament's demand, he could implement targeted changes through for example delegated acts by the first quarter of next year. Additionally, he has committed to submitting a comprehensive proposal to revise all problematic articles by 2025. This represents a major success for the European Parliament and, most importantly, for patients," stated Dr. Peter Liese, health policy spokesperson for the largest group in the European Parliament, the EPP-Christian Democrats.

"Many patients are already facing difficulties as vital medical products disappear from the market due to excessive bureaucracy. It is important to cut through this red tape not only to boost Europe's competitiveness and safeguard jobs but, in this case, in particular to address critical issues, such as treating children with heart defects. My medical colleagues have long been raising concerns, and it's crucial that we're seeing progress on these issues now," said Dr. Peter Liese, physician and MEP.

Liese added, "The Commissioner-designate, Oliver Varhelyi, left a competent impression and his stance on health policy appears satisfactory. However, I believe he has shown weaknesses, particularly in animal welfare and his previous interactions with the European Parliament, which he unfortunately did not address with an apology in his opening remarks. Reflecting the concerns of many colleagues, we have, therefore, decided to submit additional written questions. It's my hope that his responses will adequately satisfy the majority of the committee."